{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "E",
          "alt": "Q",
          "position": "487"
        },
        "variant_string_id": "PARK2 E487Q"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The abstract states that mutations in PARK2 cause early-onset Parkinson's disease and also function as tumor suppressors. Mutations abrogate the growth-suppressive effects of the PARK2 protein.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines a disease mechanism linking PARK2 dysfunction to both neurological disease and cancer, indicating that PARK2 has a growth-suppressive role."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper describes evaluating the growth-suppressive effects of the PARK2 protein. This directly relates to the defined disease mechanism of PARK2 functioning as a tumor suppressor.",
          "judgment": "Yes",
          "reasoning": "Assessing growth suppression is a relevant assay class because it directly probes the tumor suppressor function of PARK2, aligning with the defined disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The abstract does not specify details about controls or replicates used in the evaluation of PARK2 mutations and growth suppression.",
          "judgment": "No",
          "reasoning": "The abstract lacks information regarding the inclusion of both wild-type and abnormal/null controls, as well as information about the number of replicates used for the experiments."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Evaluating growth suppression is a broadly accepted method for assessing the function of tumor suppressor genes.",
          "judgment": "Yes",
          "reasoning": "Growth suppression assays are standard techniques in cancer biology and have been widely used to evaluate the function of tumor suppressor genes.",
          "next_step_or_outcome": "Functional evidence strength: Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence suggests that the PARK2 E487Q variant is pathogenic because it abrogates the growth-suppressive effects of the PARK2 protein, supporting its role as a tumor suppressor. The lack of detailed controls limits the strength to supporting."
    }
  ]
}